期刊文献+

晚期非小细胞肺癌患者运用分子靶向治疗的临床观察与护理

下载PDF
导出
摘要 肺癌目前已是我国因恶性肿瘤死亡的第一位,放化疗的毒副反应较大,且有效率也不尽如人意。近几年来分子靶向治疗走上临床,给放化疗失败的晚期非小细胞肺癌患者带来新的希望。
作者 郑丽君 李媛
出处 《医学信息(医学与计算机应用)》 2014年第22期356-356,共1页 Medical Information
  • 相关文献

参考文献4

二级参考文献27

  • 1李海云,郑毅.结缔组织病合并间质性肺疾病的研究进展[J].中华风湿病学杂志,2005,9(7):438-441. 被引量:28
  • 2于青,于兰.压力性溃疡危险因素的评估[J].护士进修杂志,1996,11(2):7-8. 被引量:126
  • 3耿红.治疗III度褥疮9例临床观察[J].实用护理杂志,1992,8(6):29.
  • 4Hidalgo M, Siu LL. Phase Ⅰ and Pharmacologic study of OSI-774, an epidermal growth factor receptor tyrosine kinase inhibitor, in patients with advanced solid malignancies[J]. J Clin Oncol, 2001,19(13):3267 - 3279.
  • 5Klapper LN, Kirschbaum MH, Sela M, et al. Biochemical and clinical implications of the ErbB/HER signaling network of growth factor receptors [ J ]. Adv Cancer Res, 2000,77: 25 - 79.
  • 6Mendrola JM, Berger MB, King MC, et al. The single transmenmbrane domains of ErbB receptors self-associate in cell membranes[J]. J Biol Chem, 2002,277(7) :4704 - 4712.
  • 7Moyer JD, Barbacci EG, Iwata KK, et al. Induction of apoptosis and cell cycle arrest by CP-358,774, an inhibitor of epidermal growth factor receptor tyrosine kinase [ J ]. Cancer Res, 1997, 57 ( 21 ):4838 - 4848.
  • 8Pollack VA, Savage DM, Baker DA, et al. Inhibition of epidermal growth factor receptor-associated tyrosine phosphorylation in human carcinoma with OSI-774: Dynamics of receptor inhibition in situ and antitumor effects in athymic mice[J]. J Pharmcol Exp Ther, 1999,291(2) :739 - 748.
  • 9Senzer NN, Soulieres D, Siu L, et al. Phase 2 evaluation of OSI-774,a potent oral antagonist of the EGFR-TK in patients with advanced squamous cell carcinoma of the head and neck [ abstract ] [ J ]. Proc Am Soc Clin Oncol, 2001,20: 2a [ Abstract 6 ].
  • 10Perez-Soler R, Chachoua A, Hammond LA, et al. Determinants of tumor response and survival with erlotinib in patients with non-small-cell lung cancer[ J]. J Clin Oncol, 2004,22(16): 3238 - 3247.

共引文献42

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部